NantKwest

NK NASDAQ
1.040
+0.020
+1.96%
盘后: 1.040 0 0.00% 16:25 06/17 EDT
开盘
1.020
昨收
1.020
最高
1.070
最低
1.020
成交量
18.08万
成交均量(3M)
57.87万
52周最高
4.230
52周最低
0.9300
换手率
0.18%
市值
1.03亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供NantKwest NK股票价格,NantKwest股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Its immuno-oncology NK platform has multiple modes to induce cell death against the tumor or infected cell by direct killing by binding to stress ligands expressed by the diseased cell with the release of toxic granules directly into the tumor cell; antibody mediated killing by binding to antibodies administered in combination and enhancing the cancer killing effect of the administered antibody, enabling targeted cell killing through antibody dependent cellular cytotoxicity (ADCC), and target activated killing by binding to known or newly discovered tumor-specific antigens expressed on the surface of tumor cells and inducing cell death by the release of toxic granules directly into the tumor cell and by the release of cytokines and chemokines.
展开 >

最近浏览

名称
价格
涨跌幅